BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12877587)

  • 21. A new role for old ligands: discerning chelators for zinc metalloproteinases.
    Jacobsen FE; Lewis JA; Cohen SM
    J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermo-induced formation of unimolecular and multimolecular micelles from novel double hydrophilic multiblock copolymers of N,N-dimethylacrylamide and N-isopropylacrylamide.
    Zhou Y; Jiang K; Song Q; Liu S
    Langmuir; 2007 Dec; 23(26):13076-84. PubMed ID: 18027977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.
    Hugenberg V; Riemann B; Hermann S; Schober O; Schäfers M; Szardenings K; Lebedev A; Gangadharmath U; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S
    J Med Chem; 2013 Sep; 56(17):6858-70. PubMed ID: 23899323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors.
    Santos MA; Marques SM; Tuccinardi T; Carelli P; Panelli L; Rossello A
    Bioorg Med Chem; 2006 Nov; 14(22):7539-50. PubMed ID: 16875829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples.
    Hesek D; Toth M; Meroueh SO; Brown S; Zhao H; Sakr W; Fridman R; Mobashery S
    Chem Biol; 2006 Apr; 13(4):379-86. PubMed ID: 16632250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.
    Breuer E; Salomon CJ; Katz Y; Chen W; Lu S; Röschenthaler GV; Hadar R; Reich R
    J Med Chem; 2004 May; 47(11):2826-32. PubMed ID: 15139760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.
    Jguirim-Souissi I; Jelassi A; Addad F; Hassine M; Najah M; Ben Hamda K; Maatouk F; Ben Farhat M; Bouslema A; Rouis M; Slimane MN
    Am J Cardiol; 2007 Jul; 100(1):23-7. PubMed ID: 17599435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
    Kapischke M; Fischer T; Tiessen K; Tschesche H; Bruch HP; Kalthoff H; Kruse ML
    Int J Oncol; 2008 Jan; 32(1):273-82. PubMed ID: 18097568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.
    Biasone A; Tortorella P; Campestre C; Agamennone M; Preziuso S; Chiappini M; Nuti E; Carelli P; Rossello A; Mazza F; Gallina C
    Bioorg Med Chem; 2007 Jan; 15(2):791-9. PubMed ID: 17088065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular remodeling and protease inhibition--bench to bedside.
    Sluijter JP; de Kleijn DP; Pasterkamp G
    Cardiovasc Res; 2006 Feb; 69(3):595-603. PubMed ID: 16387286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases.
    Skarja GA; Brown AL; Ho RK; May MH; Sefton MV
    Biomaterials; 2009 Apr; 30(10):1890-7. PubMed ID: 19147221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local delivery of 17-beta-estradiol modulates collagen content in coronary porcine arteries after PTCA and stent implantation.
    Geraldes P; Geoffroy P; Cloutier I; Sirois MG; Tanguay JF
    J Vasc Res; 2008; 45(6):503-11. PubMed ID: 18451633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid assembly of matrix metalloprotease inhibitors using click chemistry.
    Wang J; Uttamchandani M; Li J; Hu M; Yao SQ
    Org Lett; 2006 Aug; 8(17):3821-4. PubMed ID: 16898826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
    Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of ribonucleotide reductase reduces neointimal formation following balloon injury.
    Henry JC; Bonar MM; Kearns PN; Cui H; Mutchler MM; Martin MV; Orsini AR; Elford HL; Bush CA; Zweier JL; Cardounel AJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):70-6. PubMed ID: 15814568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
    Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
    J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico study of MMP inhibition.
    Rouffet M; Denhez C; Bourguet E; Bohr F; Guillaume D
    Org Biomol Chem; 2009 Sep; 7(18):3817-25. PubMed ID: 19707688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.